JP2014528948A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014528948A5 JP2014528948A5 JP2014532361A JP2014532361A JP2014528948A5 JP 2014528948 A5 JP2014528948 A5 JP 2014528948A5 JP 2014532361 A JP2014532361 A JP 2014532361A JP 2014532361 A JP2014532361 A JP 2014532361A JP 2014528948 A5 JP2014528948 A5 JP 2014528948A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- reagent
- aminosulfonyl
- thiazol
- pyridinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IVZKZONQVYTCKC-UHFFFAOYSA-N BAY 57-1293 Chemical compound N=1C(C)=C(S(N)(=O)=O)SC=1N(C)C(=O)CC(C=C1)=CC=C1C1=CC=CC=N1 IVZKZONQVYTCKC-UHFFFAOYSA-N 0.000 claims description 4
- LVLDBZCFWNSVLJ-UHFFFAOYSA-N 4-methyl-2-(methylamino)-1,3-thiazole-5-sulfonamide Chemical compound CNC1=NC(C)=C(S(N)(=O)=O)S1 LVLDBZCFWNSVLJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 10
- 150000001642 boronic acid derivatives Chemical class 0.000 claims 5
- 125000004432 carbon atoms Chemical group C* 0.000 claims 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 4
- OLDXRTOEUPVZKB-UHFFFAOYSA-N B1CCCC1 Chemical compound B1CCCC1 OLDXRTOEUPVZKB-UHFFFAOYSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 3
- -1 pyridine compound Chemical class 0.000 claims 3
- KPAUORDXNFURBA-UHFFFAOYSA-N 2-(4-pyridin-2-ylphenyl)acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=N1 KPAUORDXNFURBA-UHFFFAOYSA-N 0.000 claims 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 2
- 239000012445 acidic reagent Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- VBXDEEVJTYBRJJ-UHFFFAOYSA-N diboronic acid Chemical compound OBOBO VBXDEEVJTYBRJJ-UHFFFAOYSA-N 0.000 claims 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- SXUHSLTVWLRXCM-UHFFFAOYSA-N 1$l^{2}-borinane Chemical compound [B]1CCCCC1 SXUHSLTVWLRXCM-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 101710043771 PDCL Proteins 0.000 claims 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L Palladium(II) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 230000001808 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
- 0 *Cc(cc1)ccc1I Chemical compound *Cc(cc1)ccc1I 0.000 description 4
- CENMEJUYOOMFFZ-UHFFFAOYSA-N B1Oc(cccc2)c2O1 Chemical compound B1Oc(cccc2)c2O1 CENMEJUYOOMFFZ-UHFFFAOYSA-N 0.000 description 1
Claims (8)
- 以下に示すステップA及びステップBに従って、N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−N−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドを合成する方法。
ステップA:
次の一般式A*
R2は1〜6個の炭素原子を有するアルキル基、または3〜6個の炭素原子を有するシクロアルキル基を表す。)
で表される化合物Aを、
R1−OH、またはR1−B(OR)2の脱離下で、および、化合物Aの中間体ボロン酸誘導体の形成下で、ボロン酸誘導体試薬、ボロラン試薬、ボリナン試薬、またはジボロン酸試薬と反応させるステップであって、
ここで、前記中間体ボロン酸誘導体は、後に精製される(4−ピリジン−2−イルフェニル)酢酸を直接得るために、塩基性条件下で、次の一般式B*
で表されるピリジン化合物Bと反応させるステップ。
ステップB:
ステップAから得られる(4−ピリジン−2−イルフェニル)酢酸を4−メチル−2−(メチルアミノ)−1,3−チアゾール−5−スルホンアミド
次の式
- R1およびR3は、互いに独立して、−F、−Cl、−Br、−I、−OMs、−OTf、および−OTsから選択される、請求項1に記載の方法。
- 前記中間体ボロン酸誘導体試薬またはボロラン試薬の調製のために、前記試薬酢酸パラジウム、トリエチルアミンおよびトリフェニルホスフィン、またはPdCl2(PPh3)2およびトリエチルアミンを使用する、請求項1に記載の方法。
- ステップBは、THF/NMP溶媒混合物中でカップリング試薬としてEDC×HClと共に行われる、請求項1に記載の方法。
- 有機溶媒および水中に前記N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−N−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドを有する混合物は、昇温でメタンスルホン酸の付加で過飽和溶液を生じ、それから前記N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−N−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメタンスルホン酸一水和物は、延長された撹拌、混合、または冷却の後に結晶化する、請求項2に記載の方法。
- ステップD:
少なくとも一つの薬学的に許容できる担体、賦形剤、溶媒および/または希釈剤と共に、結晶性N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−N−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメタンスルホン酸一水和物の医薬組成物を調製すること、
をさらに含む、請求項1〜請求項7のいずれか一項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11007823A EP2573086A1 (en) | 2011-09-26 | 2011-09-26 | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP11007823.5 | 2011-09-26 | ||
PCT/EP2012/068938 WO2013045479A1 (en) | 2011-09-26 | 2012-09-26 | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016249351A Division JP6353022B2 (ja) | 2011-09-26 | 2016-12-22 | N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−n−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメシレート一水和物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014528948A JP2014528948A (ja) | 2014-10-30 |
JP2014528948A5 true JP2014528948A5 (ja) | 2015-10-15 |
JP6161614B2 JP6161614B2 (ja) | 2017-07-12 |
Family
ID=46889067
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014532361A Active JP6161614B2 (ja) | 2011-09-26 | 2012-09-26 | N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−n−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメシレート一水和物 |
JP2016249351A Active JP6353022B2 (ja) | 2011-09-26 | 2016-12-22 | N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−n−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメシレート一水和物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016249351A Active JP6353022B2 (ja) | 2011-09-26 | 2016-12-22 | N−[5−(アミノスルホニル)−4−メチル−1,3−チアゾール−2−イル]−n−メチル−2−[4−(2−ピリジニル)フェニル]アセトアミドメシレート一水和物 |
Country Status (29)
Country | Link |
---|---|
US (1) | US9340535B2 (ja) |
EP (3) | EP2573086A1 (ja) |
JP (2) | JP6161614B2 (ja) |
KR (4) | KR20180088530A (ja) |
CN (2) | CN105541829A (ja) |
AR (3) | AR088043A1 (ja) |
AU (2) | AU2012314536B2 (ja) |
BR (1) | BR112014003245B1 (ja) |
CA (1) | CA2791142C (ja) |
CL (1) | CL2014000149A1 (ja) |
DK (2) | DK2598501T3 (ja) |
ES (2) | ES2466221T3 (ja) |
HK (1) | HK1220978A1 (ja) |
HR (1) | HRP20140351T1 (ja) |
IL (2) | IL230152A (ja) |
IN (1) | IN2014DN01993A (ja) |
JO (2) | JO3037B1 (ja) |
MX (2) | MX371088B (ja) |
MY (2) | MY185063A (ja) |
PE (1) | PE20141148A1 (ja) |
PH (1) | PH12015502801B1 (ja) |
PL (2) | PL2602258T3 (ja) |
PT (1) | PT2598501E (ja) |
RU (2) | RU2669388C1 (ja) |
SG (1) | SG10201407430TA (ja) |
TW (2) | TWI567070B (ja) |
UA (2) | UA115317C2 (ja) |
WO (1) | WO2013045479A1 (ja) |
ZA (2) | ZA201401773B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2573086A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
UA123734C2 (uk) * | 2016-04-06 | 2021-05-26 | Інновейтів Молекьюлз Ґмбх | Похідні амінотіазолу, отримані як противірусні засоби |
HUE054845T2 (hu) | 2016-11-28 | 2021-10-28 | Aicuris Gmbh & Co Kg | Az N-[5-(amino-szulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamid szabad bázis maleát sója, gyógyászati készítmények, elõállítási eljárások és Herpes vírusok kezelésére történõ alkalmazások |
EP4201934A1 (en) * | 2016-11-28 | 2023-06-28 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof |
WO2018095576A1 (en) * | 2016-11-28 | 2018-05-31 | Aicuris Anti-Infective Cures Gmbh | Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide |
KR102335327B1 (ko) | 2017-04-28 | 2021-12-03 | 현대자동차 주식회사 | 수냉식 이지알 쿨러 |
NZ760339A (en) * | 2017-06-28 | 2023-06-30 | Aicuris Gmbh & Co Kg | Intravaginally applicable devices comprising antiviral compounds |
UA126163C2 (uk) | 2017-10-05 | 2022-08-25 | Інновейтів Молекьюлз Ґмбх | Енантіомери серії противірусних сполук |
US11964969B2 (en) | 2018-07-06 | 2024-04-23 | Phaeno Therapeutics Co., Ltd | Crystal forms of thiazole compound and application thereof |
CA3113353A1 (en) * | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | High-purity peg lipids and uses thereof |
TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
WO2024047507A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | A novel crystalline form of pritelivir |
WO2024047508A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
WO2024047506A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | A novel crystalline form of pritelivir |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
DE10129716A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
DE10129717A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
DE10129714A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
DE10131128A1 (de) * | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
GB0423653D0 (en) * | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
DE102005014248A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
JP2007314516A (ja) * | 2006-04-25 | 2007-12-06 | Daiichi Sankyo Co Ltd | 2以上の置換基を有するベンゼン化合物を含有する医薬 |
WO2007146838A2 (en) * | 2006-06-09 | 2007-12-21 | Icos Corporation | Substituted phenyl acetic acids as dp-2 antagonists |
AR070127A1 (es) * | 2008-01-11 | 2010-03-17 | Novartis Ag | Pirrolo - pirimidinas y pirrolo -piridinas |
UA103918C2 (en) * | 2009-03-02 | 2013-12-10 | Айерем Элелси | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators |
EP2573085A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
EP2573086A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
-
2011
- 2011-09-26 EP EP11007823A patent/EP2573086A1/en not_active Withdrawn
-
2012
- 2012-09-21 TW TW105109173A patent/TWI567070B/zh active
- 2012-09-21 TW TW101134784A patent/TWI532739B/zh active
- 2012-09-23 JO JOP/2012/0276A patent/JO3037B1/ar active
- 2012-09-26 KR KR1020187021891A patent/KR20180088530A/ko active Application Filing
- 2012-09-26 PL PL13157396T patent/PL2602258T3/pl unknown
- 2012-09-26 PT PT127623007T patent/PT2598501E/pt unknown
- 2012-09-26 IN IN1993DEN2014 patent/IN2014DN01993A/en unknown
- 2012-09-26 MX MX2015016192A patent/MX371088B/es unknown
- 2012-09-26 EP EP13157396.6A patent/EP2602258B8/en active Active
- 2012-09-26 CN CN201511005819.8A patent/CN105541829A/zh active Pending
- 2012-09-26 JP JP2014532361A patent/JP6161614B2/ja active Active
- 2012-09-26 DK DK12762300.7T patent/DK2598501T3/da active
- 2012-09-26 AR ARP120103551A patent/AR088043A1/es not_active Application Discontinuation
- 2012-09-26 KR KR1020177012548A patent/KR20170055565A/ko active Search and Examination
- 2012-09-26 UA UAA201404411A patent/UA115317C2/uk unknown
- 2012-09-26 MX MX2014003389A patent/MX338736B/es active IP Right Grant
- 2012-09-26 US US14/347,287 patent/US9340535B2/en active Active
- 2012-09-26 PL PL12762300T patent/PL2598501T3/pl unknown
- 2012-09-26 BR BR112014003245-9A patent/BR112014003245B1/pt active IP Right Grant
- 2012-09-26 CA CA2791142A patent/CA2791142C/en active Active
- 2012-09-26 MY MYPI2014000656A patent/MY185063A/en unknown
- 2012-09-26 ES ES13157396.6T patent/ES2466221T3/es active Active
- 2012-09-26 CN CN201280046744.6A patent/CN103842359B/zh active Active
- 2012-09-26 ES ES12762300.7T patent/ES2462492T3/es active Active
- 2012-09-26 KR KR1020147004026A patent/KR101768295B1/ko active IP Right Grant
- 2012-09-26 UA UAA201704493A patent/UA119574C2/uk unknown
- 2012-09-26 AU AU2012314536A patent/AU2012314536B2/en active Active
- 2012-09-26 EP EP12762300.7A patent/EP2598501B1/en active Active
- 2012-09-26 RU RU2017114501A patent/RU2669388C1/ru active
- 2012-09-26 RU RU2014107430A patent/RU2620604C2/ru active
- 2012-09-26 PE PE2014000390A patent/PE20141148A1/es active IP Right Grant
- 2012-09-26 DK DK13157396.6T patent/DK2602258T3/da active
- 2012-09-26 MY MYPI2017702805A patent/MY190878A/en unknown
- 2012-09-26 WO PCT/EP2012/068938 patent/WO2013045479A1/en active Application Filing
- 2012-09-26 KR KR1020197025387A patent/KR20190104249A/ko not_active Application Discontinuation
- 2012-09-26 SG SG10201407430TA patent/SG10201407430TA/en unknown
-
2013
- 2013-12-24 IL IL230152A patent/IL230152A/en active IP Right Grant
-
2014
- 2014-01-20 CL CL2014000149A patent/CL2014000149A1/es unknown
- 2014-03-11 ZA ZA2014/01773A patent/ZA201401773B/en unknown
- 2014-04-14 HR HRP20140351AT patent/HRP20140351T1/hr unknown
- 2014-09-01 IL IL234405A patent/IL234405A/en active IP Right Grant
- 2014-09-02 HK HK16109165.2A patent/HK1220978A1/zh unknown
- 2014-11-27 ZA ZA2014/08734A patent/ZA201408734B/en unknown
-
2015
- 2015-11-24 AU AU2015260762A patent/AU2015260762B2/en active Active
- 2015-12-16 PH PH12015502801A patent/PH12015502801B1/en unknown
-
2016
- 2016-06-07 JO JOP/2016/0114A patent/JO3734B1/ar active
- 2016-12-22 JP JP2016249351A patent/JP6353022B2/ja active Active
-
2019
- 2019-09-13 AR ARP190102595A patent/AR116394A2/es unknown
-
2020
- 2020-10-23 AR ARP200102938A patent/AR120291A2/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014528948A5 (ja) | ||
HRP20140351T1 (hr) | N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamid mezilat monohidrat | |
CN102414202B (zh) | 制备取代异噁唑啉化合物及其前体的方法 | |
JP2008523069A5 (ja) | ||
JP2010513494A5 (ja) | ||
JP2017522357A5 (ja) | ||
JP2012515142A5 (ja) | ||
JP2015500335A5 (ja) | ||
CN105294699A (zh) | 巴瑞替尼的制备方法 | |
JP5654462B2 (ja) | 貧溶媒添加法による2−(3−シアノ−4−イソブチルオキシフェニル)−4−メチル−5−チアゾールカルボン酸の結晶多形体の製造方法 | |
KR101067069B1 (ko) | 트리플루오로아세트산을 이용한 페난트리딘 유도체의 제조방법 | |
JP2008526918A5 (ja) | ||
CN101857559B (zh) | 手性α-(三氯甲基)胺类化合物及其制备方法 | |
JP2013531021A (ja) | フェブキソスタットの結晶形iiを調製するための方法 | |
JP2008533169A5 (ja) | ||
JP2013525473A5 (ja) | ||
BR112015015880B1 (pt) | Processos de produção de um composto e compostos | |
CN111057087A (zh) | 一种非对称噻吩[7]螺烯同分异构体及其制备方法和应用 | |
JP7027541B2 (ja) | ジシクロヘキサンジカルボン酸ジエステルの製造方法およびジシクロヘキサンジカルボン酸の製造方法 | |
TWI361807B (en) | Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
TW201429953A (zh) | 吡唑化合物的結晶的製造方法 | |
JP5803031B2 (ja) | ペレチノインの向上した合成 | |
JP7316228B2 (ja) | 化合物および化合物の製造方法 | |
CN101774962B (zh) | 化合物2-(1,3-二羰基异二氢吲哚-2-基)-3-取代基丙-2-烯酸的制备方法 | |
JP2013526573A5 (ja) |